During today's session, shares of Divis Laboratories experienced a rise of 2.07 percent, with the current price at Rs 6586.00. This increase marks a notable movement for the company, which is included in both the NIFTY NEXT 50 and NIFTY 100 indices.
Financial Performance Overview
Divis Laboratories has demonstrated notable financial performance over the recent quarters. Here’s a snapshot of the company's key financial metrics:
Quarterly Performance:
| Period | Revenue (Cr) | Net Profit (Cr) | EPS |
|---|---|---|---|
| Mar 2024 | Rs 2,303.00 | Rs 538.00 | 20.25 |
| Jun 2024 | Rs 2,118.00 | Rs 430.00 | 16.20 |
| Sep 2024 | Rs 2,338.00 | Rs 510.00 | 19.20 |
| Dec 2024 | Rs 2,319.00 | Rs 589.00 | 22.20 |
| Mar 2025 | Rs 2,585.00 | Rs 662.00 | 24.93 |
The annual financial performance of Divis Laboratories from 2021 to 2025 reveals consistent growth in revenue and net profit. Key highlights include:
| Year | Revenue (Cr) | Net Profit (Cr) | EPS | BVPS | ROE | Debt to Equity |
|---|---|---|---|---|---|---|
| 2021 | Rs 6,969.40 | Rs 1,984.29 | 74.75 | 350.15 | 21.34 | 0.00 |
| 2022 | Rs 8,959.83 | Rs 2,960.45 | 111.52 | 441.82 | 25.24 | 0.00 |
| 2023 | Rs 7,767.51 | Rs 1,823.38 | 68.69 | 480.96 | 14.28 | 0.00 |
| 2024 | Rs 7,845.00 | Rs 1,600.00 | 60.27 | 512.11 | 11.78 | 0.00 |
| 2025 | Rs 9,360.00 | Rs 2,191.00 | 82.53 | 564.87 | 14.63 | 0.00 |
The company's income statement data highlights a consistent increase in total income and net profit over the years. Sales have grown from Rs 6,969 Cr in 2021 to Rs 9,360 Cr in 2025. Similarly, net profit has risen from Rs 1,984 Cr in 2021 to Rs 2,191 Cr in 2025.
Cash Flow:
| Year | Operating Activities | Investing Activities | Financing Activities | Net Cash Flow |
|---|---|---|---|---|
| Mar 2021 | Rs 1,946 | Rs 75 | Rs -34 | Rs 1,987 |
| Mar 2022 | Rs 1,911 | Rs -2,194 | Rs -532 | Rs -815 |
| Mar 2023 | Rs 2,459 | Rs -2,707 | Rs -797 | Rs -1,045 |
| Mar 2024 | Rs 1,261 | Rs -269 | Rs -799 | Rs 193 |
| Mar 2025 | Rs 1,653 | Rs -804 | Rs -799 | Rs 50 |
| Year | Share Capital | Reserves & Surplus | Current Liabilities | Total Liabilities | Fixed Assets | Current Assets | Total Assets |
|---|---|---|---|---|---|---|---|
| Mar 2021 | Rs 53 | Rs 9,241 | Rs 1,112 | Rs 10,774 | Rs 4,414 | Rs 6,174 | Rs 10,774 |
| Mar 2022 | Rs 53 | Rs 11,675 | Rs 1,195 | Rs 13,374 | Rs 4,794 | Rs 8,351 | Rs 13,374 |
| Mar 2023 | Rs 53 | Rs 12,714 | Rs 1,101 | Rs 14,438 | Rs 4,934 | Rs 9,311 | Rs 14,438 |
| Mar 2024 | Rs 53 | Rs 13,518 | Rs 1,278 | Rs 15,470 | Rs 5,517 | Rs 9,675 | Rs 15,470 |
| Mar 2025 | Rs 53 | Rs 14,916 | Rs 1,452 | Rs 16,932 | Rs 6,463 | Rs 10,081 | Rs 16,932 |
Divis Laboratories exhibits strong financial health based on key ratios:
| Ratio | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Basic EPS (Rs.) | 74.75 | 111.52 | 68.69 | 60.27 | 82.53 |
| Book Value/Share (Rs.) | 350.15 | 441.82 | 480.96 | 512.11 | 564.87 |
| Dividend/Share (Rs.) | 20.00 | 30.00 | 30.00 | 30.00 | 30.00 |
| P/E (x) | 48.47 | 39.47 | 41.10 | 57.16 | 69.98 |
| P/B (x) | 10.37 | 9.97 | 5.88 | 6.71 | 10.22 |
According to Moneycontrol analysis, the current market sentiment for Divis Laboratories is very bullish as of May 21, 2025. With the stock currently trading at Rs 6586.00, Divis Laboratories has demonstrated a positive trend in today's session, reflecting investor confidence and robust financial metrics.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
